SEC Form 4 · accession 0001123292-15-000749
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julie Hambleton
Officer — SVP & Chief Medical Officer
Period of report
Apr 30, 2015
Accepted (ET)
May 4, 2015 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 30, 2015 | A | 7,980 | $0.00 | A | 9,979 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of restricted stock, which will vest fully on January 3, 2017, provided the reporting person remains employeed by the Company.
- F2Reflects the acquisition of 1,108 shares on May 15, 2014 pursuant to the Five Prime Therapeutics, Inc. 2013 Employee Stock Purchase Plan (the "ESPP") and the acquisition of 891 shares on November 15, 2014 pursuant to the ESPP.